Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90

Journal of Medicinal Chemistry
Jean-Yves Le BrazidecMarcus F Boehm

Abstract

The heat shock protein Hsp90 has increasingly become an important therapeutic target especially for treatment of cancers. Inhibition of the ATPase activity of Hsp90 by natural products (e.g., 17-allylaminogeldanamycin or radicicol) leads to the ubiquitination of oncogenic client proteins such as Her-2, Raf-1, and p-Akt followed by their proteasomal degradation. Hsp90 inhibitors simultaneously target multiple oncogenic proteins and provide an advantage for cancer therapy due to the potential for increased efficacy and overcoming drug resistance. In an effort to convert geldanamycin into a druglike compound with better pharmacokinetic properties and efficacy in human tumor xenograft models, geldanamycin was derivatized on the 17-position to prepare new analogues such as 17-geldanamycin amides, carbamates, and ureas and 17-arylgeldanamycins. All the compounds were first evaluated ex vivo using a cell-based Her-2 degradation assay and in vitro using biochemical assays that measure recombinant Hsp90 (rHsp90) competitive binding and changes in rHsp90 conformation. In addition, we confirmed the selectivity of geldanamycin analogues for Hsp90 derived from tumor cells using a novel cell lysate binding assay.

References

Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·L WhitesellL M Neckers
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·C SchneiderF U Hartl
Feb 19, 2000·Current Opinion in Structural Biology·L H Pearl, C Prodromou
Jan 5, 2002·Expert Opinion on Biological Therapy·Alison Maloney, Paul Workman
Oct 23, 2003·Seminars in Oncology·David B SolitNeal Rosen

❮ Previous
Next ❯

Citations

Aug 1, 2013·Pathology Oncology Research : POR·J M Patki, S S Pawar
Jun 19, 2013·European Journal of Medicinal Chemistry·Stefania TerraccianoGiuseppe Bifulco
Mar 19, 2013·The Journal of Organic Chemistry·Russell R A Kitson, Christopher J Moody
Jun 21, 2011·Organic Letters·Min YinBen Shen
May 21, 2008·Organic Letters·Hua-Li Qin, James S Panek
Jun 19, 2013·Chemical Communications : Chem Comm·Russell R A Kitson, Christopher J Moody
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qian XieGeorge F Vande Woude
Aug 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Carmel T ChanSanjiv S Gambhir
Apr 7, 2005·Applied and Environmental Microbiology·Leandro VetcherZhihao Hu
Aug 2, 2005·Neuro-oncology·Michael W Graner, Darell D Bigner
Mar 29, 2014·Chemical Reviews·Madhu AeluriPrabhat Arya
Nov 23, 2006·Journal of Pharmaceutical Sciences·Allyn M Kaufmann, Jeffrey P Krise
Oct 24, 2009·Cancer Letters·Yayoi FukuyoNobuo Horikoshi
Aug 16, 2005·Biochemical and Biophysical Research Communications·M NomuraJ Yamashita
Apr 25, 2006·Biochemical and Biophysical Research Communications·Yuo-Sheng ChangYiu-Kay Lai
Jan 31, 2006·Expert Opinion on Therapeutic Targets·Gabriela Chiosis
Jan 14, 2009·Bioorganic & Medicinal Chemistry·Yuanming LuBrian S J Blagg
Oct 29, 2010·Chemistry : a European Journal·Christian RinkMartin E Maier
Feb 8, 2007·Organic & Biomolecular Chemistry·Iain A Inverarity, Alison N Hulme
Apr 12, 2008·Angewandte Chemie·Justin K Belardi, Glenn C Micalizio
Jul 29, 2009·Chembiochem : a European Journal of Chemical Biology·Markus UgeleMartin E Maier
May 21, 2011·Chemistry, an Asian Journal·Jonghoon KimSeung Bum Park
Dec 1, 2019·Chemical Biology & Drug Design·Nilüfer BayrakAmaç Fatih Tuyun
May 27, 2015·Medicinal Research Reviews·Anuj KhandelwalBrian S J Blagg
Jan 18, 2018·Organic & Biomolecular Chemistry·Zhe Meng, Bo Liu
Jan 4, 2008·Cancer Research·Carmel T ChanSanjiv Sam Gambhir
Sep 15, 2019·Bioorganic & Medicinal Chemistry·David Bickel, Holger Gohlke
Dec 14, 2006·ACS Chemical Biology·Gabriela Chiosis, Len Neckers
Dec 14, 2006·ACS Chemical Biology·Muralikrishna DuvvuriJeffrey P Krise
Apr 27, 2019·Journal of Medicinal Chemistry·Audrey E Yñigez-Gutierrez, Brian O Bachmann
Nov 19, 2015·Journal of Chemical Theory and Computation·Kira A ArmacostCharles L Brooks
Nov 24, 2005·Journal of Medicinal Chemistry·Yves L Janin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.